• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Alexion Pharmaceuticals

Alexion Pharmaceuticals

Alexion Pharmaceuticals Inc ALXN

Last Price$127.22Day Change (%)-4.84%
Open Price$131.60Day Change ($)-6.47
Day Range127.18–132.3052-Week Range110.56–193.45

As of Fri 9/23/2016 5:00:00 PM | USD

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. Alexion Employees Volunteer Together in Company’s First Global Day of Service

    Alexion Employees Volunteer Together in Company’s First Global Day of Service

  2. Alexion Launches Uncommon Strength Campaign to Unite and Celebrate the Courage and Resilience of People Living with Rare Diseases

    Alexion Launches Uncommon Strength Campaign to Unite and Celebrate the Courage and Resilience of People Living with Rare Diseases

  3. Everbridge to Showcase Safety Connection™ and Growing Partner Ecosystem at ASIS 2016

    Everbridge to Showcase Safety Connection™ and Growing Partner Ecosystem at ASIS 2016

  4. Moderna Enters New Growth Phase with Closing of $474 Million Equity Financing and its First BARDA Grant for up to $125 Million for Zika mRNA Vaccine

    Moderna Enters New Growth Phase with Closing of $474 Million Equity Financing and its First BARDA Grant for up to $125 Million for Zika mRNA Vaccine

  5. Arterial Calcification Global Clinical Trials Review, H2, 2016 - Analysis, Technologies & Forecasts Report - Key Vendors: Medestea Internazionale, Amgen, VitaK - Research and Markets

    Arterial Calcification Global Clinical Trials Review, H2, 2016 - Analysis, Technologies & Forecasts Report - Key Vendors: Medestea Internazionale, Amgen, VitaK - Research and Markets

  6. European Commission Grants Orphan Drug Designation to ALXN1007 for the Treatment of Patients with Graft-Versus-Host Disease (GVHD)

    European Commission Grants Orphan Drug Designation to ALXN1007 for the Treatment of Patients with Graft-Versus-Host Disease (GVHD)

  7. Medalist Funds Like These Large-Cap Stocks

    We crunch the numbers to see which stocks are most widely held among analyst-recommended large-cap funds.

  8. Our 5 Nominees for Domestic-Stock Fund Manager of the Year

    Standing out in a good year for stocks.

  9. Which Funds Own My Stock?

    Ownership data provide a look at who else owns the company.

  10. How to Avoid Unpleasant Surprises

    Buying a country or sector fund isn't as easy as it seems.

12
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.